Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03684980
Title LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma - ARM A
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center

B-cell lymphoma

central nervous system lymphoma


Glucarpidase + Leucovorin + Methotrexate + Rituximab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.